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Background: Lassa virus and Marburg virus are two causative agents of viral hemorrhagic fever. Their diagnosis is
difficult because patients infected with either pathogen present similar nonspecific symptoms early after infection.
Current diagnostic tests are based on detecting viral proteins or nucleic acids in the blood, but these cannot be
found during the early stages of disease, before the virus starts replicating in the blood. Using the transcriptional
response of the host during infection can lead to earlier diagnoses compared to those of traditional methods.
Results: In this study, we use RNA sequencing to obtain a high-resolution view of the in vivo transcriptional dynamics
of peripheral blood mononuclear cells (PBMCs) throughout both types of infection. We report a subset of host mRNAs,
including heat-shock proteins like HSPA1B, immunoglobulins like IGJ, and cell adhesion molecules like SIGLEC1, whose
differences in expression are strong enough to distinguish Lassa infection from Marburg infection in non-human
primates. We have validated these infection-specific expression differences by using microarrays on a larger set of
samples, and by quantifying the expression of individual genes using RT-PCR.
Conclusions: These results suggest that host transcriptional signatures are correlated with specific viral infections, and
that they can be used to identify highly pathogenic viruses during the early stages of disease, before standard
detection methods become effective.
Keywords: Transcriptomics, Transcriptional response, Lassa virus, Marburg virus, Interferon-stimulated genes, Biomarker,
Gene expression profile, Early stage diagnosticsBackground
Lassa fever and Marburg fever are acute viral hemorrhagic
illnesses. Lassa Fever is caused by the Lassa virus and it is
endemic to a large region of West Africa, where 100,000-
300,000 cases have been estimated to occur each year [1].
More than 20 cases have been imported to the United
States, Canada, United Kingdom and Japan since 1969,
when the disease was first recognized [2,3]. The case fatal-
ity rate in hospitalized patients has recently been reported
to be 69% [4]. Marburg fever is a viral hemorrhagic illness
caused by the Marburg virus. Several outbreaks have been
reported in the Democratic Republic of the Congo [5] and
Angola [6] with case fatality rates approaching 90%. Trav-
elers visiting Uganda have also imported the virus into the
Netherlands [7] and the United States [8]. Both diseases
lack effective therapeutics and early diagnostics.* Correspondence: nacho@bu.edu
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unless otherwise stated.Early clinical symptoms of infection are shared between
different hemorrhagic fevers, and they resemble those
of a flu-like illness: fever, headache, myalgia, sore throat,
vomiting, diarrhea and dry cough [9]. During the 2014
West Africa Ebola outbreak, samples from suspected
patients were routinely tested to rule out infection by
Lassa virus, since both pathogens were present in the
region and distinguishing between them was an important
part of the differential diagnosis [10,11].
Current diagnostic tests for Lassa and Marburg fevers
include enzyme-linked immunosorbent assays (ELISA)
and reverse transcriptase polymerase chain reaction
(RT-PCR) [12-14]. Because these methods rely on the
direct detection of viral proteins or nucleic acids in the
blood, they are not useful during the incubation period
of the virus, which happens during the early stages of
infection [9,13]. Additionally, most potential therapies
for these pathogens—ribavirin [15], post-infection vaccin-
ation [16], and stable nucleic acid-lipid particle (SNALP)
treatment [17]—work best when administered early.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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early stages of disease would positively impact survival.
One approach for developing more rapid diagnostics
involves incorporating the host response to infection as
part of the diagnostic assay. During an infection, circulat-
ing immune cells are present in high numbers and they
respond to distress signals from many different tissues by
altering the levels of expression of specific genes. These
changes in expression often take place before the virus
starts replicating in the blood (viremia) [18,19] (Figure 1C),
which means that they could be used to perform earlier
diagnoses than those allowed by traditional methods. To
ensure that the predictive power of these changes in
expression can distinguish between different causative
agents, the host gene expression profiles associated with
each type of infection must be determined in advance.
Two recent reports have used a host response signature to
discriminate symptomatic patients with viral infections
from those infected with bacteria [20,21]. An RT-PCR
assay has also been developed and clinically tested [20].
We have analyzed the transcriptome of PBMCs from
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Figure 1 Quantified samples in each virus group. (A) Each circle repres
cells (PBMCs) of a cynomolgus macaque. Grey indicates pre-infection samp
samples infected with Lassa virus, and red indicates samples infected with
with a black border were also quantified using RNA sequencing. (B) Diagra
events, from the appearance of fever 3 days post-infection to the late stagLassa virus [18] and to Marburg virus [Lee et al., manu-
script in preparation], and we have found that the circulat-
ing immune cells develop a robust antiviral response days
before clinical symptoms. In this article, we show that the
expression differences in the genes that make up this
response can be used to distinguish between Lassa and
Marburg infections as early as 3 days after exposure.
Results
Clinical symptoms
Animals were exposed to an aerosol dose of 1000 plaque
forming units of Lassa [18] or Marburg virus [Lee et al.,
manuscript in preparation], as previously described. In
these models, animals began to develop a fever around
day 3 after exposure to Lassa virus and day 4 after
exposure to Marburg virus (Table 1). The onset of
viremia took place around day 8 for Lassa and day 4 for
Marburg (confirmed by both plaque assay and RT-PCR).
The liver enzymes aspartate transaminase (AST) and
alanine transaminase (ALT) showed increased levels of
concentration in both diseases around day 6. D-dimers
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ents an RNA sample isolated from the peripheral blood mononuclear
les, each coming from a different cynomolgus macaque. Blue indicates
Marburg virus. All samples were quantified using microarrays. Samples
m of the disease timecourse highlighting the most relevant clinical
e of disease and death (see also Table 1).
Table 1 Times at which clinical markers are detected in
each type of infection
Lassa Marburg
Fever Day 3 Day 4
Viremia Day 8 Day 4
Increased AST/ALT Day 6 Day 6
Increased D-dimers Day 5 Day 6
Viremia was measured using RT-PCR in the Lassa group, and RT-PCR and
plaque assay in the Marburg group.
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peaked during the late stages of infection (days 9–10).
These data confirmed that clinical markers of infection
that could be used for diagnosis (e.g. viremia) did not
appear in these models until day 4 post-infection.RNA sequencing
To determine the transcriptional changes that take
place in the circulating immune system in response to a
hemorrhagic fever virus infection, we quantified the
abundance of mRNAs present in peripheral blood mono-
nuclear cells (PBMCs) of cynomolgus macaques infected
with either Lassa or Marburg virus. The samples were
obtained before the animals were infected, and at multiple
times after infection (see Figure 1A). We selected for poly-
adenylated transcripts and sequenced 12 RNA samples
from each group using Illumina technology. This process
generated an average of 46.27 ± 5.92 million reads per
sample; 72% of which (33.46 ± 4.33 million) aligned to
the M. mulatta (Rhesus macaque) genome—the closest
organism to M. fascicularis with an annotated genome.
Multiple factors may explain why 28% of reads remained
unaligned: an incomplete assembly of the M. mulatta
genome and transcriptome, genetic differences between
M. mulatta and M. fascicularis, or the appearance of
amplification artifacts during the sequencing process.
We assessed the expression level of individual mRNAs
by counting the number of reads that aligned uniquely
to each gene, and then normalizing this number to
allow comparisons across all samples.
To determine the amount of sequencing reads that
came from each virus, we aligned the reads to the Lassa
virus and Marburg virus genomes. In the Lassa infection
group, only the samples taken 10 days post-infection
(dpi) contained viral reads (less than 20 reads) (Figure 1B).
In the Marburg infection group, around 2000 viral
reads were seen 5 dpi, and around 80,000 reads 9 dpi
(Figure 1C). These numbers suggest that peripheral
blood mononuclear cells are early targets for Marburg
virus but not for Lassa virus. The number of viral reads
found in PBMCs correlates well with the level of
viremia, as previously reported for Lassa virus [18] and
Marburg virus [Lee et al., manuscript in preparation].The common transcriptional response of PBMCs during
Lassa and Marburg infection is dominated by type I
interferon-stimulated genes
To identify what transcriptional changes are shared by
different hemorrhagic fever virus infections, we identi-
fied genes whose levels of expression 1) closely matched
in both types of viral challenge, 2) strongly increased or
decreased 3 days post-infection (dpi), and 3) increased
or sustained this level of expression throughout the
remaining time points (5–10 dpi). We labeled this group
of genes the common response (Figure 2B). Some of its
representative members include transcription factors
IRF7 and STAT1, which serve as master regulators of
host immunity; pattern recognition receptors DDX58
(RIG-I), IFIH1 (MDA-5) and DHX58 (LGP2), which ac-
tivate different signaling cascades in the innate immune
system; type I interferon-stimulated genes ISG15, ISG20,
OAS1, OAS2, OASL, MX1, IFIT1, IFIT2, IFIT3, HERC5,
HERC6, IFI6, IFI35, IFI44 and IFI44L, which play a variety
of antiviral roles [22]; and the cytokine CXCL10, which
attracts activated T cells [23] (Additional file 1).
A subset of genes shows unique patterns of expression in
each type of infection
After identifying the subset of genes that made up the
common transcriptional response, we looked for genes
that showed unique transcriptional patterns. To do this,
we considered genes that 1) showed a statistically signifi-
cant increase or decrease in their 3 dpi levels of expres-
sion for one type of viral infection but not the other, and
2) increased or sustained this difference in expression
throughout the later stages of the infection.
In the Lassa infection group, we detected several genes
with distinctly upregulated expression (Figure 3 and
Additional file 1), including SIGLEC1, a cell adhesion
molecule expressed by dendritic cells and macrophages
[24,25]; SAMD4, a translational repressor [26]; and TNK2,
a tyrosine kinase implicated in cell spreading and migra-
tion [27]. Other genes, like CENPF, ENPP4, and GZMA, a
protease responsible for the release of cytotoxic T-cell
granules [28], were significantly downregulated during
Lassa infection in comparison to Marburg infection.
In the Marburg infection group, we identified a distinct
upregulation in the expression of genes encoding heat
shock proteins (HSPA1B, HSPA1L and DNAJA1), the
antiapoptotic gene BIRC3, and the immunoglobulin genes
IGJ, IGLV10-54, among others. We also found genes that
showed lower levels of expression during Marburg infec-
tion when compared to Lassa infection. Examples of these
include PLK3, a kinase associated with stress response and
apoptosis [29,30]; and NR4A2, a nuclear receptor which
has been shown to induce apoptosis when downregulated
[31]. The patterns of expression for these and other genes
are shown in Additional files 2 and 3.




























































































Figure 2 Genes showing similar patterns of expression during Lassa virus and Marburg virus infection. Each point represents the level of
expression (measured in log10 normalized read counts) of a gene that behaves similarly in both types of infection (increasingly darker shades of blue
for Lassa, and red for Marburg). Panel (A) represents the expression of gene IFI44L showing time in the x-axis. Panel (B) condenses the information in
(A) and shows additional genes along the x-axis.
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using microarrays and RT-PCR
We wanted to know if the genes that showed significant
differences in each type of infection could be used to
classify unknown samples. Although we were not able to
obtain an independent test dataset, we used additional
samples from two previous studies to characterize the
host transcriptional response to Lassa [18] and Marburg
infection [Lee et al., manuscript in preparation] (Additional
files 4 and 5). This dataset included the 24 samples that
we measured using RNA sequencing, as well as 26 add-
itional uninfected samples, 12 Lassa-infected samples and
3 Marburg-infected samples (Figure 1A), for a total of 65
samples, all of which were quantified using Agilent two-
color human microarrays. We looked at the genes that we
had previously identified (using RNA sequencing) as beingdifferentially expressed during one of the two infections,
and found that the measurements from both platforms
were highly correlated (0.81 Pearson’s correlation).
To understand in more detail the differences in ex-
pression reported by RNA sequencing and microarrays,
we classified a subset of genes into four categories: 1)
Housekeeping genes, those that showed high levels of
expression across all samples. 2) Common response
genes, those where infected samples show higher levels
of expression than uninfected samples, and where these
levels of expression were similar in both types of infec-
tion. 3) Marburg-specific response genes, those where
Marburg-infected samples showed significantly higher
(or lower) patterns of expression when compared to
uninfected or Lassa-infected samples. 4) Lassa-specific
response genes, those where Lassa-infected samples
Figure 3 Gene expression patterns during Lassa or Marburg virus infection. A few representative genes are shown in each panel representing
each category: A) housekeeping genes, genes that uniformly increase or decrease their expression 3 days after both infections, B) genes that show
unique patterns of expression during Lassa infection, and C) during Marburg infection. The y-axis represents the average fold change in expression
when comparing infected and uninfected samples.
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compared to uninfected or Marburg-infected samples.
To determine if we could use the genes showing unique
regulation at early times of infection to distinguish between
different types of infected samples, we applied Multidi-
mensional Scaling (MDS)—a dimensionality reduction
technique similar to Primary Component Analysis—to the
microarray samples. Instead of applying MDS on theexpression of every gene, we chose a subset of common
response genes, Marburg-specific response genes and
Lassa-specific response genes (see Figure 4). Reducing
the dimensionality of all samples using these genes resulted
in three clear clusters: uninfected samples, infected with
Lassa virus, and infected with Marburg virus. Each of
the infected clusters contained not only the early-
infected samples, but also those samples taken at later

































Figure 4 Clustering of microarray samples. Each point corresponds to an RNA sample, and their distances represent how similar they are
based on applying Multidimensional Scaling to the microarray expression values of 16 genes: 4 common response genes (MX1, OAS1, IFI44L and
CXCL10), 4 Marburg-specific response genes (HSPA1B, IGJ, HSPA1L and BIRC3) and 4 Lassa-specific response genes (SIGLEC1, TNK2, TNFSF10 and
NR4A2). Lassa- and Marburg-infected samples are shown in increasingly darker shades of blue and red, respectively.
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patterns of these genes are useful indicators throughout
both early and late stages of infection.
We then looked at the reported expression levels for
these genes in both platforms (Figure 5). We only used
samples that were quantified in both sequencing and
arrays to ensure that differences in variability would only
be related to the platform, not to the number of samples.
The majority of genes showed similar levels of expression
in both platforms. The biggest differences came from
genes like HSPA1L and IGJ, which showed much smaller
fold changes in arrays than in sequencing. On average,
both highly upregulated and downregulated genes showed
fold changes with a 1.5-2 times smaller magnitude in
arrays when compared to sequencing.
This comparison confirmed that both RNA sequencing
and microarrays show unique changes in mRNA levels
early after infection. This led us to test the hypothesis
that a more direct RT-PCR analysis of a small number
of these sentinel genes would show similar patterns of
unique regulation, with the advantage that the format of
this assay could be applied more quickly and cheaply in
the field. We chose to analyze the expression of two
genes, SIGLEC1 and HSPA1B, which showed unique
upregulation at early stages of Lassa or Marburg virus
infection, respectively. RT-PCR assays carried out on
uninfected samples, and on samples collected 3 days
post-infection, showed that there was no statistically
significant change in SIGLEC1 expression between these
two time points in Marburg-infected animals, but thatthere was a 70-fold change in expression in Lassa-infected
animals. Similarly, HSPA1B showed a minor change in
Lassa-infected animals, but a 36-fold change in Marburg-
infected animals. This confirmed that SIGLEC1 becomes
upregulated during the early stages of Lassa infection but
not Marburg infection, while HSPA1B is only upregulated
during the early stages of Marburg infection (Figure 6).
Discussion
In the work described in this manuscript, we investigated
the hypothesis that the circulating immune response
can be used to aid early diagnosis of viral infections
that are associated with high levels of mortality. When
we analyzed the transcriptional patterns of the circulating
immune system in response to two different hemorrhagic
fever viruses, we identified a subset of genes that uniquely
increased their rate of transcription 3 days after infection
and that sustained these differences throughout infection
(Figure 3).
An important aspect of this study was that the
uniquely regulated genes were not the only genes that
changed their patterns of expression during the early
times of infection (before the detection of clinical symp-
toms), but that many other genes—pattern recognition
receptors, interferon-stimulated genes, cytokines, and
immune and antiviral transcriptional regulators—also
became rapidly upregulated. This suggests that early
after infection, there is a strong activation of the type I
interferon innate immune response. This early innate



































































































































































Figure 5 Biomarker genes quantified using RNA sequencing and microarrays. For each gene, the y-axis represents its amount of expression
in each RNA sample, and the x-axis represents these samples ordered by time of infection, colored in increasingly darker shades of blue for Lassa,
and red for Marburg. The samples in (A) were quantified using RNA sequencing and the fold change represents the log2 difference between the
average infected and uninfected normalized read counts. The samples in (B) were measured using two-color microarrays and the fold change
represents the log2 ratio between the intensity of the red channel and the green channel (see Methods).
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http://www.biomedcentral.com/1471-2164/15/960viruses, such as Ebola [32], influenza [33] and respiratory
syncytial virus (RSV) [34], and suggests that the activation
of the innate immune system is being driven by a different
mechanism. Surprisingly, we did not detect a significant
upregulation of type I interferon genes, although we didsee it for their downstream effectors. Protein studies indi-
cate that type I interferon is present during Marburg virus
infection, suggesting that interferon transcription might
be localized to plasmacytoid dendritic cells, which are not

















Figure 6 3 dpi RT-PCR validation. SIGLEC1 and HSPA1B are the genes
with the highest fold change differences between each virus group
3 days post-infection. The y-axis represents the difference in expression
between each gene and the constitutively expressed gene BIN2. The
RT-PCR reactions for each gene were performed in duplicate (n = 2).
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we observed at early times of infection, we also identified
a number of genes with unique patterns of expression in
each type of infection. The unique markers of Marburg
infection were generally classifiable into functional cat-
egories, including heat-shock proteins (HSPA1B, HSPA1L,
DNAJA1) and immunoglobulin-associated genes (IGJ,
IGLV10-54). These results suggest that the response to
Marburg infection leads to the expansion of both stress
adaptive and immunological maturation pathways at very
early times of infection.
Some of the most uniquely expressed genes during
Lassa infection are SIGLEC1 (also known as CD169 or
sialoadhesin) and SAMD4A. The upregulation of these
genes suggests an increase in SIGLEC1+ SAMD4A +
macrophages early in Lassa infection [25,36]. A more
detailed understanding of the mechanisms leading to the
unique signatures identified will require further investi-
gation. While both Lassa virus and Marburg virus are
known to evade antiviral responses by inhibiting the
expression of specific host genes [37,38], it is unlikely
that these mechanisms are directly responsible for the
expression differences that we found in PBMCs, since
they take place during the pre-viremic stages of infection.
The specific differences observed take place even in the
absence of any viral genetic material in the PBMCs, which
suggests that these circulating cells are responding to
an external signal. An alternative explanation for the
existence of unique signatures might be related to eachpathogen’s cell tropism: Marburg virus preferentially
targets monocytes, macrophages, dendritic cells and
Kupffer cells [39], and leads to significant lymphocyte
apoptosis [40]. Lassa virus targets dendritic cells, Kupffer
cells, hepatocytes, adrenal cortical cells and endothelial
cells [41], and is not known to induce lymphocyte de-
creases. It is possible that a combination of which cells
become initially infected and the magnitude of the early
response combine to ultimately produce the infection-
specific signatures that we observe.
We have shown that microarrays can be used to validate
the changes in expression that take place in Lassa- and
Marburg-infected PBMCs in addition to RNA sequencing.
Although the majority of genes that undergo significant
early changes in expression were highly correlated in both
platforms, microarrays showed a smaller range of gene
expression differences between both types of infected
samples and greater variability. Three previous studies
that analyzed the immune response to Lassa virus in-
fection [18,42] and LCMV virus infection [43] were in
general agreement with the major trends that we identi-
fied using RNA sequencing: mainly the upregulation of
interferon-stimulated genes, pattern recognition receptors
and pro-inflammatory cytokines.
The infection-specific transcriptional changes that we
have found suggest a method for discriminating between
diseases with similar early clinical symptoms, as is the
case for Lassa and Marburg infection. In infected animals,
these transcriptional changes take place prior to the
appearance of viremia and other overt symptoms [18],
and they remain sustained throughout the late stages of
infection, thereby providing a way to diagnose which
virus is most likely causing the infection. This diagnosis
can be carried out during the early time window when
treatment is most effective, and before the pathogen
starts replicating in the bloodstream on a massive scale.
To ensure that an RT-PCR-based diagnostic would be
able to distinguish between diseases other than Lassa
and Marburg disease, it would be important to determine
the host transcriptional response to additional pathogens
like influenza virus, dengue virus or the malaria parasite,
which cause similar initial symptoms to those of viral
hemorrhagic fevers.
Conclusions
The expression of a unique set of host genes increases
or decreases preferentially in Lassa- or Marburg-infected
immune cells. During Marburg virus infection, heat-shock
protein and immunoglobulin genes show significantly
greater levels of expression than during Lassa virus infec-
tion, which is characterized by the upregulation of the cell
adhesion molecule SIGLEC1, the translational repressor
SAMD4A and the tyrosine kinase TNK2. These changes
in expression appear early after infection and remain
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provides a way to diagnose which virus is most likely to be
causing the infection without having to wait until the
appearance of viremia or other overt symptoms. The fact
that these changes were identified using multiple plat-
forms (RNA sequencing, microarrays and RT-PCR) sug-
gests a path for translating these gene expression profiles
into a diagnostic test with direct clinical applications.
Methods
Animals
The samples used in this study came from a larger sequen-
tial sampling study designed to characterize the disease
progression of viral hemorrhagic fevers after aerosol expos-
ure [Honko et al., manuscript in preparation].
Ethics statement
Animal studies were carried out in accordance with
standards of IACUC approved protocol in compliance
with the regulations outlined in the USDA Animal Welfare
Act (PHS Policy), and other Federal statutes and regula-
tions relating to experiments involving animals. The facility
where this research was conducted is accredited by the
Association for Assessment and Accreditation of Labo-
ratory Animal Care International and all animal work
adheres to the conditions specified in the Guide for the
Care and Use of Laboratory Animals (National Research
Council, [44]). These experiments and procedures were
approved by the USAMRIID Animal Care and Use Com-
mittee (IACUC). Animals were given enrichment regularly
as recommended by the Guide for the Care and Use of
Laboratory Animals. The animals were fed and checked at
least daily according to the protocol. All efforts were made
to minimize painful procedures; the attending veterinarian
was consulted regarding painful procedures, and animals
were anesthetized prior to phlebotomy. Following the de-
velopment of clinical signs, animals were checked multiple
times daily. When clinical observations and scores reached
defined levels based on the approved IACUC Animal Care
and Use Committee protocol, the animals were eutha-
nized under anesthesia to minimize pain and distress.
LASV sequential sampling study
For this study, seven adult male and female cynomolgus
macaques (Macaca fascicularis), ranging in weight from
5.5 to 8.7 kg were obtained from licensed and approved
vendors. During the acclimation to the biosafety level 4
(BSL4) containment suite, a pre-challenge blood sample
(8 days before exposure) was collected to provide a base-
line for further analyses. (These samples are referred to in
this manuscript as pre-infection or 0 days post-infection
samples.) On day 0, NHPs were anesthetized and minute
volumes calculated by performing whole-body plethys-
mography (Buxco Research Systems, Wilmington, NC)just prior to the exposure. NHPs were exposed individu-
ally at a target dose of 1000 Plaque Forming Unit (PFU)
of LASV Josiah in a head-only chamber in a class III
biological safety cabinet maintained under negative pres-
sure within a BSL-4 laboratory. Aerosols were created
by a 3-jet Collison nebulizer (BGI Inc., Waltham, MA)
and controlled by the USAMRIID Automated Bioaerosol
Exposure System (ABES-II). The virus preparation used to
infect NHPs was free of contamination of endotoxin
and mycoplasma. After challenge, blood samples were
collected at various days post-infection (dpi), based on
approved collection allowances, as well as at euthanasia.
Groups of two to three NHP were euthanized at 3, 6, 8
and 10 dpi, and peripheral blood mononuclear cells
(PBMCs) were prepared from collected blood.MARV sequential sampling study
The Marburg study was performed under the same con-
ditions as the Lassa study, with three differences:
1) The virus strain used was MARV Angola, 2) the num-
ber of adult male and female macaques was nine, and 3)
macaques were euthanized and PBMCs collected from
blood at 1, 3, 5, 7 and 9 dpi.RNA processing
PBMCs were isolated from blood pre-diluted with saline
using ACCUSPIN System-Histopaque-1077 tubes as per
manufacturer’s recommendations, and subsequently lysed
in TRI Reagent LS (Sigma-Aldrich, St. Louis, MO) at
USAMRIID.Next-generation sequencing
Library preparation
A subset of the total RNA samples from both datasets was
processed for RNA sequencing (Figure 1A). Sequencing
libraries were prepared for mRNA sequencing using
TruSeq v2 RNA Sample Preparation kits (Illumina, San
Diego, CA). Briefly, per the manufacturer protocol, mRNA
was purified from approximately 500 ng to 1 μg of total
RNA per sample using poly-T oligo-attached magnetic
beads, then fragmented and primed with random hexam-
ers for cDNA synthesis. Multiple indexing adapters were
ligated to the ends of the double-stranded cDNA, and the
DNA fragments with adapter molecules on both ends
were then selectively PCR enriched to create the sequen-
cing libraries. Libraries were validated for size and purity
on an Agilent 2100 Bioanalyzer using the DNA-1000 chip
(Agilent Technologies, Santa Clara, CA) before they were
normalized and pooled for multiplex sequencing. Cluster
generation and sequencing were performed by the Ana-
lytical Core Facility at Tufts University (Department of
Physiology).
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After sequencing the Macaca fascicularis PBMC RNA
samples from both types of infection (Lassa and Marburg),
the generated reads were trimmed and the adapters were
removed using Trimmomatic [45]. The processed reads
were aligned to the Macaca mulatta genome (Ensembl
release 75) using TopHat 2.0.6 [46] with default para-
meters (segment length of 25, allowing up to 2 segment
mismatches) and using the RhesusBase2 [47] annotated
M. mulatta transcriptome as reference. Gene counts were
obtained using HTSeq [48] to count reads that aligned
uniquely to each gene. Counts were normalized to com-
pensate for differences in library size using the trimmed
mean of M-values normalization method [49] included in
the edgeR BioConductor package [50]. The normalized
sequenced reads were also aligned to the Lassa virus
(NCBI BioProject accession PRJNA14864) and Marburg
virus (NCBI BioProject accession PRJNA15199) genomes
using BWA [51] to quantify the number of viral reads in
each sample.
A gene was deemed to show statistically significant
changes in expression at a specific time after infection
if the moderated t-test [50] between the infected and
pre-infection samples resulted in a multiple testing-
corrected p-value lower than 0.05, with an absolute fold
change in expression greater or equal to 3, and an aver-
age number of reads across all samples greater than 4
counts per million (CPM). When calculating relative
changes to the pre-infection samples, infected samples
were not subtracted from their individual uninfected
controls (since not every infected sample had a pre-infected
control), but from an average of all the pre-infection sam-
ples. Statistical significance, however, was calculated using
the individual pre-infection samples, not their average.
DNA microarrays
Sample preparation
PBMCs were processed for microarray analysis as described
previously [52]. Briefly, total RNA was extracted from the
TRI Reagent LS samples, then amplified using the Low-
Input Quick Amp Labeling kit (Agilent Technologies, Santa
Clara, CA) and hybridized to Whole Human Genome
Oligo Microarrays (Agilent Technologies, Santa Clara, CA)
in a 2-color comparative format along with a reference pool
of messenger RNA. Images were scanned using the Agilent
High-Resolution Microarray Scanner and raw microarray
images were processed using Agilent’s Feature Extraction
software.
Fold-change analysis
Agilent two-color human gene expression microarrays
were processed using limma [53]. Fold changes were
obtained by calculating the log-ratio between the intensities
of the red channel (which corresponds to experimentalsamples) and the green channel (which corresponds to
Human Universal Reference RNA [54]). These were later
background-corrected and normalized using LOESS [55].
Multidimensional scaling
The limma [53] implementation of Multidimensional
Scaling was used to reduce the dimensionality of a
matrix composed of the expression values of the follow-
ing 16 genes across the 66 RNA samples: MX1, OAS1,
IFI44L, CXCL10, HSPA1B, IGJ, HSPA1L, BIRC3, SIGLEC1,
TNK2, TNFSF10, NR4A2.
Reverse transcriptase polymerase chain reaction
RT-PCR reactions were carried out in 50 μL reactions using
Power SYBR® Green RNA-to-CT™ 1-Step Kit from Life
Technologies: 25 μL SYBR® Green RT-PCR Mix, 2 μL of
each primer at 100 μM, and .4 μL RT Enzyme Mix. Ther-
mal cycling was conducted as follows: 30 minutes at 48°C,
10 minutes at 95°C, 15 seconds at 95°C (40 cycles), and
1 minute at 60°C (40 cycles). The primer sequences used
were: SIGLEC1 (FWD) 5′-TCCTGAGTGTACTCTATCC
C-3′ (REV) 5′-TCGACAGTGCAGACAAAC-3′; BIRC3
(FWD) 5′-ACTTGAACAGCTGCTATCT-3′ (REV) 5′-TC
TTCTGAATGGTCTTCTCC-3′; BIN2 (FWD) 5′-CTCC
TGAGGCCAAAGAAA-3′ (REV) 5′-AGGCTCTGAAGC
AATCTG-3′. BIN2 was chosen as the control gene because
sequencing analysis showed it was highly expressed across
all samples and had a small relative standard deviation.
Availability of supporting data
The sequencing data sets supporting the results of this
article are available in the Sequence Read Archive (SRA)
under accession numbers PRJNA222891 (Lassa) and
PRJNA222892 (Marburg). The microarray datasets are
available in the Gene Expression Omnibus (GEO) database,
under series record GSE41752 (LASV) [18] and GSE58287
(MARV) [Lee et al., manuscript in preparation].Additional files
Additional file 1: List of genes categorized as common response, more
highly expressed in Marburg, or more highly expressed in Lassa. Columns
include the Ensembl gene ids, gene names, and the corresponding category.
Additional file 2: Visual representation of genes categorized as
more highly expressed in Lassa. The x-axis represents time and the
y-axis represents normalized read counts.
Additional file 3: Visual representation of genes categorized as
more highly expressed in Marburg. The x-axis represents time and
the y-axis represents normalized read counts.
Additional file 4: Table of gene normalized read counts during Lassa
infection. Columns include the Ensembl gene ids, gene names, and the
mean normalized read counts and standard deviations for each timepoint.
Additional file 5: Table of gene normalized read counts during
Marburg infection. Columns include the Ensembl gene ids, gene
names, and the mean normalized read counts and standard deviations
for each timepoint.
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